Mechanisms of action of topically applied triamcinolone acetonide in prolonging skin allograft survival time.
D000287:Administration, Topical; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D002417:Cattle; D005260:Female; D006084:Graft Rejection / Q000187:drug effects*; D006969:Hypersensitivity, Immediate; D007109:Immunity / Q000187:drug effects; D007116:Immunization, Passive; D007249:Inflammation; D007271:Injections, Intradermal; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D011817:Rabbits; D012710:Serum Albumin, Bovine / Q000008:administration & dosage; D016038:Skin Transplantation; D013154:Spleen / Q000166:cytology / Q000276:immunology / Q000637:transplantation; D013997:Time Factors; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous; D014222:Triamcinolone Acetonide / Q000008:administration & dosage*
D000893:Anti-Inflammatory Agents; D012710:Serum Albumin, Bovine; D014222:Triamcinolone Acetonide